VERRALAB JA LLC NPI 1821360017

NPI Details

VERRALAB JA LLC is a clinical medical laboratory in Louisville, KY. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. VERRALAB JA LLC NPI is 1821360017. The provider is registered as an organization entity type.
The provider Is Doing Business As Biotap Medical.

The provider's business location address is:

716 W MAIN ST STE 100A
LOUISVILLE, KY
ZIP 40202-777
Phone: (502) 566-3588
Fax: (502) 561-0089

The provider's authorized official is Kristen Reynolds .
The authorized official title is President and has the following contact phone number (502) 566-3588.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Identification of organisms by genetic analysis, amplified probe technique (HCPCS:87150)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0483)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0481)
• 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0004)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0482)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique (HCPCS:87491)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Detection of mycoplasma genitalium by dna or rna probe (HCPCS:87563)
• Hepatitis c antibody measurement (HCPCS:86803)
• Hepatitis b core antibody (igm) measurement (HCPCS:86705)
• Detection test by immunoassay technique for hepatitis b surface antigen (HCPCS:87340)
• Detection test by immunoassay technique for hiv-1 antigen and hiv-1 and hiv-2 antibodies (HCPCS:87389)
• Hepatitis b surface antibody measurement (HCPCS:86706)
• Analysis for antibody, treponema pallidum (HCPCS:86780)
• Hepatitis b core antibody measurement (HCPCS:86704)
• Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique (HCPCS:87591)
• Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique (HCPCS:87661)
• Detection test by nucleic acid for hepatitis c virus, quantification (HCPCS:87522)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Gene analysis (cytochrome p450, family 2, subfamily d, polypeptide 6) common variants (HCPCS:81226)
• Gene analysis (cytochrome p450, family 2, subfamily c, polypeptide 9) common variants (HCPCS:81227)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Gene analysis (cytochrome p450, family 2, subfamily c, polypeptide 19) common variants (HCPCS:81225)
• Molecular pathology procedure (HCPCS:81479)
• Gene analysis (cytochrome p450 family 3 subfamily a member 4) for common variant (HCPCS:81230)
• Gene analysis (cytochrome p450 family 3 subfamily a member 5) for common variant (HCPCS:81231)
• Gene analysis (solute carrier organic anion transporter family, member 1b1) for common variant (HCPCS:81328)
• Gene analysis (vitamin k epoxide reductase complex subunit 1) common variants (HCPCS:81355)
• Hemoglobin a1c level (HCPCS:83036)
• Magnesium level (HCPCS:83735)
• Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus (HCPCS:87637)
• Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique (HCPCS:87581)
• Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique (HCPCS:87486)
• Vitamin d-3 level (HCPCS:82306)

The enumeration date for this NPI number is 2/2/2012 and was last updated on 3/28/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.